Lexaria Bioscience Corp. — Director's Dealing 2025

May 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2025-05-15

Reporting Person: DOCHERTY JOHN MARTIN (Director, President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-15	Stock Options	$1.04	A	150000	Acquired	2030-05-15	Common Shares (150000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	54075	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3	2026-04-26	Common Shares (18000)	18000	Direct
Stock Options	$3	2026-06-08	Common Shares (18334)	36334	Direct
Stock Options	$3	2026-09-01	Common Shares (15000)	51334	Direct
Stock Options	$2.91	2027-08-29	Common Shares (30000)	81334	Direct
Stock Options	$1.15	2028-10-26	Common Shares (30000)	111334	Direct
Stock Options	$2.36	2029-04-26	Common Shares (49500)	160834	Direct